Skip to content
StockMarketAgent
Direct answer
EMR trades against a final fair-value range of $88.69-$155.92, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs. Fair value range: low $88.7, high $156, with mid-point at $122.
Stock analysis

EMR fair value $89–$156

By StockMarketAgent.AI team· supervised by
分析日: 2026-05-13更新日: 次回更新: 2026-08-13Methodology v2.5Review: automatedArchetype: Mature compounder
View archive
株価
$137.28
▼ -15.07 (-10.98%)
公正価値
$122
$89–$156
評価
縮小
confidence 87/100
上昇余地
-11.0%
upside to fair value
安全余裕率
$103.88
MoS level · 15%
時価総額
$76.9B
P/E fwd 19.2

§1 エグゼクティブサマリー

  • Composite fair value $122 with high case $156.
  • Implied downside of 11.0% to fair value.
  • Moat 9/10 · confidence 87/100 · Mature compounder.
  • Currently screens above fair value, so patience matters more than entry speed.
Fair value
$122
Margin of safety
-12.3%
Confidence
87/100
Moat
9/10

Educational analysis only — not financial advice. Always do your own due diligence.

$137.28Price
Low $88.69
Mid $122.21
High $155.92

EMR trades against a final fair-value range of $88.69-$155.92, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.

  • High switching costs associated with
    High switching costs associated with mission-critical process automation platforms like DeltaV.
  • Sticky, high-margin software and service
    Sticky, high-margin software and service recurring revenue base.
  • Bull thesis
    Reduce-side internal valuation cross-checks ($164.87) aggressively prices in perfect execution of the M&A synergy playbook and permanent retention of 24.2% outlier margins.

§2 ベアケース

A synchronized global industrial recession combined with delays in clean energy CAPEXCapital expendituresCash spent on acquiring or upgrading property, plant, and equipment. Splits into maintenance capex (sustaining current capacity) and growth capex (expanding capacity). stalls near-term automation spending. The newly acquired software segments fail to offset hardware cyclicality, causing margins to revert to the 16% historical peer average.

このテーゼが崩れる経路

M&A Value Destruction

20%· Medium

Failure to extract synergies from recent software acquisitions causes ROIC to stagnate below WACC, driven by the $18B goodwill burden.

FV impact
$88.69 (Implies ~35% downside)

Automation CAPEX Freeze

25%· Medium

Macroeconomic weakness and deferred conventional energy projects significantly halt process automation spending across key markets.

FV impact
Significant multiple compression to 15x legacy industrial norms.

Margin Reversion

30%· Medium

Current 24.2% operating margins prove unsustainable and revert to the 16% historical industry norm amidst competitive pricing pressures.

FV impact
Downside to the Multi-Stage Moat Fade midpoint of $77.53.
監視すべき早期警戒シグナル
指標現在トリガーしきい値
Consecutive quarters of declining software and services recurring revenue.MonitorDeterioration versus the report thesis
Operating margins compressing below the 21% normalized assumption.MonitorDeterioration versus the report thesis
Unadjusted ROIC falling further below current 6.9% due to asset bloat.MonitorDeterioration versus the report thesis
Significant downward revisions in forward private EPS estimate reference.MonitorDeterioration versus the report thesis
Management pausing or cutting the dividend/buyback program to preserve cash.MonitorDeterioration versus the report thesis

§3 財務履歴

損益計算書 — 直近6期
項目T−0T−1T−2T−3CAGR
期間2022-09-302023-09-302024-09-302025-09-30Trend
売上高$13.80B$15.17B$17.49B$18.02B+9.3%
売上総利益$6.31B$7.43B$8.89B$9.52B+14.7%
営業利益$2.36B$2.76B$2.67B$3.53B+14.4%
純利益$3.23B$13.22B$1.97B$2.29B-10.8%
EPS (希薄化後)$5.41$22.88$3.43$4.04-9.3%
EBITDA$3.50B$4.22B$4.03B$4.84B+11.4%
研究開発
販管費$3.61B$4.19B$5.14B$5.10B+12.2%

品質スコア

OCF / 純利益
1.35×
>1 は利益の質が高いことを示す
会計品質ゲート
Fail
セクター調整後ゲート
ROIC
7.7%
投下資本利益率
セクション 3

Numbers analysis

キャッシュフロー

Cash-flow quality is reflected in the OCFOperating cash flowCash generated from the company's core operations after working-capital changes but before capital expenditures. The first line of the cash-flow statement. / net incomeNet IncomeNet Income is an income-statement line item used to reconcile revenue to operating profit, pre-tax income, net income, or per-share earnings. It should be compared across periods and against peer disclosure conventions., accounting-quality, and ROICROICReturn on invested capital. Operating profit (after tax) divided by invested capital. The single best gauge of capital-efficiency. Spread over WACC = economic value created. rows above.

資本配分

Capital allocation should be evaluated against reinvestment needs, balance-sheet strength, and shareholder returns.

個人サブスクライバー — §4以降11セクション追加

完全な分析を読む — 11セクション追加。

Competitive moat, industry cycle, peer comparison, intrinsic valuation, sensitivity, scenarios, earnings decision tree, position management, investor perspectives, scorecard, and final recommendation.

カバー対象の全ティッカーの完全なレポート
24か月分の評価アーカイブ
ウォッチリストブリーフィング + 評価変更アラート
任意の言語でのPDF + DOCXエクスポート
無料トライアルを開始
いつでもキャンセル可能。
FAQ

EMR — frequently asked questions

  1. Based on our latest analysis, EMR screens modestly overvalued. The current price is $137 versus a composite fair-value midpoint of $122 (range $88.7–$156), which implies roughly 11.0% downside to the midpoint.
Related coverage

Names readers of EMR also follow

Same archetype: mature-compounder